RUA Life Sciences (LON:RUA) Shares Down 10.9% – Time to Sell?

RUA Life Sciences plc (LON:RUA) shares fell 10.9% on Friday . The stock traded as low as GBX 14.03 and last traded at GBX 14.03. 601,581 shares traded hands during mid-day trading, an increase of 128% from the average session volume of 263,286 shares. The stock had previously closed at GBX 15.75.

RUA Life Sciences Stock Down 7.4%

The stock’s 50 day moving average is GBX 13.06 and its 200 day moving average is GBX 12.02. The company has a market capitalization of £9.05 million, a PE ratio of -2.61 and a beta of 1.21. The company has a debt-to-equity ratio of 5.42, a quick ratio of 7.32 and a current ratio of 9.01.

RUA Life Sciences (LON:RUA) last released its quarterly earnings data on Friday, January 30th. The company reported GBX (0.23) earnings per share for the quarter. RUA Life Sciences had a negative net margin of 65.72% and a negative return on equity of 26.38%.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.